Dr. Hommat Hommadov, MD

Dr. Hommadov practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Hommadov's NPI, 1144679580, was assigned on June 7, 2016. Dr. Hommadov holds New Jersey license 25MA12052900.

Dr. Hommadov's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Hommadov's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Hommadov is also affiliated with Temple University Hospital. The medical group on file is Mid-Atlantic Permanente Medical Group. Dmand AI also links Dr. Hommadov to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hommadov practices. Vendor and product names are available with a free account.

Anesthesiology is Dr. Hommadov's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dmand AI has Dr. Hommadov's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 111 Medicare services from Dr. Hommadov across 6 procedure codes in 2024, for 244 Medicare patients. Medicare paid $13,300 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 244 Medicare patients who saw Dr. Hommadov in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hommadov's median patient age at 48, with 75% women.

In 2018, Dr. Hommadov wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $43 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Hommadov for performance year 2024, reported as part of a group. Dr. Hommadov accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Hommadov from 3 drug and device companies in 2018. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $124.